University_of_Minnesota
Minneapolis, Minnesota, 55454, United States
NCT Number: NCT01875094
This is a feasibility study of using health-IT to promote self-management of risk factors in stroke survivors.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Phase 1 / Phase 2
Minneapolis, Minnesota, 55454, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Cannot use the health-IT system
Time frame: 3 months
The American Heart Association/American Stroke Association (AHA/ASA) have cited the JNC-7 in their guidelines to define normal blood pressure as < 120/80. We will use these guidelines and examine rates (percentage of subjects) of blood pressure control in intervention vs. usual care group.
Time frame: 3 months
Percent of subjects who have discontinued one or more of the blood pressure medications on their own (i.e. without medical direction) in the intervention vs. usual care group.
Time frame: 3 months
Ease of online health management tool use will be operationalized as the percent of subjects in the intervention group who measure their BP and enter it online at least 75% of the study period, 50% of the study period and those with 25% or less of the study period.
University of Minnesota
Other
Promoting Self-Management in Stroke Survivors Using Health IT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06248190
Asthma, Behavior
Pietermaritzburg, KwaZulu-Natal, South Africa
View Trial DetailsNCT04705779
Body Weight, Brain Diseases
Chapel Hill, North Carolina, United States
View Trial Details